In ATC, it has been observed that Glioma-associated oncogene antagonist-61 [45] and resveratrol [46] possess the potential to elicit anti-tumor effects through the inhibition of the JAK/STAT pathway. The gene discussed is SOAT1; the disease is central nervous system cancer.